TrialGynecologic oncology2010

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.

Halla S Nimeiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.